GREAT POINT PARTNERS LLC
CIK 1281446 · last filed 2015-03-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CNXR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
GREENWICH, CT 06830
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apyx Medical Corp (BVX) Delisted | 480,000 | — | — | $0 | 2 | 2015-03-18 | |
| CONNECTURE INC (CNXR) Delisted | 10%+ Owner | 5,898,851 | — | — | -$19.00M | 1 | 2014-12-17 |
| ALBIREO PHARMA, INC. (BIOD) Delisted | Director | 36,414 | — | — | -$1.59M | 9 | 2010-01-13 |
| MEMY | 10%+ Owner | 5,330,339 | $14.05 | $74.89M | -$6.63M | 3 | 2007-11-06 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | 10%+ Owner | 2,216,700 | — | — | -$7.31M | 1 | 2007-01-18 |
Recent Filings · Page 2 of 2
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-10-07 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −31,838 | -$166.4K | EDGAR |
| 2009-09-18 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −21,334 | -$110.9K | EDGAR |
| 2009-09-08 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −12,600 | -$63.3K | EDGAR |
| 2009-09-03 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −4,046 | -$20.4K | EDGAR |
| 2009-08-20 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −13,000 | -$65.0K | EDGAR |
| 2007-12-05 | — | Exer (X) | +4,500,000 | $0 | |
| 2007-11-06 | MEMY | Sell (S) | −1,139,400 | -$1.16M | EDGAR |
| 2007-10-24 | MEMY | Sell (S) | −1,232,000 | -$1.15M | EDGAR |
| 2007-10-17 | MEMY | Sell (S) | −4,133,090 | -$4.31M | EDGAR |
| 2007-01-18 | INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Sell (S) | −1,000,000 | -$7.31M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.